Fellows
Andy Liao.jpg

Chih-Yi (Andy) Liao, MD

Third-year Fellow (entered program in 2014)

Clinical Focus

  • Solid tumors

Research Focus

  • Clinical trials
  • Developmental therapeutics

Type of Research

  • Clinical

Profile

Education
BA, University of California Berkeley, Berkeley, CA
MD, Vanderbilt University, Nashville, TN
Post-graduate Training
Internal Medicine Residency, Rush University, Chicago, IL

Publications

  • Breast cancer
    Liao C
    In: The Washington Manual of Hematology and Oncology Subspecialty Consult 4th Edition. Philadelphia: Wolters Kluwer, 2016
  • Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors
    Puzanov I, Lee W, Chen AP, Calcutt MW, Hachey DL, Vermeulen WL, Spanswick VJ, Liao CY, Hartley JA, Berlin JD, Rothenberg ML
    Clin Cancer Res 2011 Jun 1;17(11):3794-802
  • Development of new strategies for renal cell carcinoma therapy
    Puzanov I, Liao C
    Farmakoterapie 2008;5:438-439. Review.